Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Optimal duration of risperidone or olanzapine adjunctive therapy to mood stabilizer following remission of a manic episode: A CANMAT randomized double-blind trial.
Yatham LN, Beaulieu S, Schaffer A, Kauer-Sant'Anna M, Kapczinski F, Lafer B, Sharma V, Parikh SV, Daigneault A, Qian H, Bond DJ, Silverstone PH, Walji N, Milev R, Baruch P, da Cunha A, Quevedo J, Dias R, Kunz M, Young LT, Lam RW, Wong H. Yatham LN, et al. Among authors: walji n. Mol Psychiatry. 2016 Aug;21(8):1050-6. doi: 10.1038/mp.2015.158. Epub 2015 Oct 13. Mol Psychiatry. 2016. PMID: 26460229 Free PMC article. Clinical Trial.
HER2-enriched subtype and novel molecular subgroups drive aromatase inhibitor resistance and an increased risk of relapse in early ER+/HER2+ breast cancer.
Bergamino MA, López-Knowles E, Morani G, Tovey H, Kilburn L, Schuster EF, Alataki A, Hills M, Xiao H, Holcombe C, Skene A, Robertson JF, Smith IE, Bliss JM, Dowsett M, Cheang MCU; POETIC investigators. Bergamino MA, et al. EBioMedicine. 2022 Sep;83:104205. doi: 10.1016/j.ebiom.2022.104205. Epub 2022 Aug 16. EBioMedicine. 2022. PMID: 35985932 Free PMC article.
Effect of Celecoxib vs Placebo as Adjuvant Therapy on Disease-Free Survival Among Patients With Breast Cancer: The REACT Randomized Clinical Trial.
Coombes RC, Tovey H, Kilburn L, Mansi J, Palmieri C, Bartlett J, Hicks J, Makris A, Evans A, Loibl S, Denkert C, Murray E, Grieve R, Coleman R, Borley A, Schmidt M, Rautenberg B, Kunze CA, Rhein U, Mehta K, Mousa K, Dibble T, Lu XL, von Minckwitz G, Bliss JM; Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators. Coombes RC, et al. JAMA Oncol. 2021 Sep 1;7(9):1291-1301. doi: 10.1001/jamaoncol.2021.2193. JAMA Oncol. 2021. PMID: 34264305 Free PMC article. Clinical Trial.
The revised Approved Instructional Resources score: An improved quality evaluation tool for online educational resources.
Grock A, Jordan J, Zaver F, Colmers-Gray IN, Krishnan K, Chan T, Thoma B, Alexander C, Alkhalifah M, Almehlisi AS, Alqahtani S, Anderson S, Anderson S, Andrews C, Andruko J, Antony N, Aryal D, Backus B, Baird J, Baker A, Batty S, Baylis J, Beaumont B, Belcher C, Benavides B, Benham M, Botta J, Berger Pelletier E, Bouchard N, Brazil V, Brumfield E, Bryson A, Bunchit W, Butler K, Buzikievich L, Calcara D, Carey R, Carrillo MR, Carroll S, Lyons C, Cassidy L, Challen K, Chan K, Chaplin T, Chatham-Zvelebil N, Chen E, Chen L, Chhabra S, Chin A, Chochi E, Choudhri T, Christensen J, Connors K, Coppersmith V, Cosgrove A, Costello G, Cullison K, D'Alessandro A, Wit K, Decock M, Delbani R, Denq W, Deutscher J, Devine B, Dorsett M, Duda T, Dueweke J, Dunphy T, Dyer S, Eastley KT, Edmonds M, Edwards K, Ehrman R, Elkhalidy Y, Fedor P, Ficiur B, Flynn C, Fraser B, Fu M, Fukakusa J, Funk E, Gaco D, Gawlik V, Ghaffarian K, Gharahbaghian L, Griffith A, Griffith P, Gronowski T, Grossman C, Gucwa J, Gupta P, Gustafson A, Guy A, Haas M, Haciski S, Hajdinjak E, Hall AK, Hammock R, Hansel J, Hart A, Hattin L, Herb B, Hilbert S, Hill J, Hill J, Ho A, House E, House N, Huang SYM, Huffman J, Inboriboon C, … See abstract for full author list ➔ Grock A, et al. Among authors: walji n. AEM Educ Train. 2021 May 16;5(3):e10601. doi: 10.1002/aet2.10601. eCollection 2021 Jul. AEM Educ Train. 2021. PMID: 34141997 Free PMC article.
30 results